Facts on:
Recalls
FDA-Approved Prescription Drugs Later Pulled From The Market By The FDA -
Drug Safety: Most Drugs Withdrawn In Recent Years Had Greater Health Risks For Women - 1/19/2001
More Blood Pressure Medication Recalled: Company Recalls 80 Lots Of Valsartan Over Cancer Concerns - 1/2/2019
Recall Alert: Macleods Pharmaceuticals Pulls Losartan From Shelves - 2/26/2019
FDA Wants All Zantac Products Pulled; Probable Carcinogen Levels Increase During Storage - 9/18/2019
It's Not Just Zantac - More Heartburn Drugs Pulled From Shelves Due To Potential Cancer Risk - 1/10/2020
FDA Requests Removal Of All Ranitidine Products (Zantac) From The Market - 4/1/2020
FDA Recalls All Ranitidine (Zantac) Products, Citing Increased Risk Of Cancer - 4/1/2020
CVS Pulls 2 Store-Brand Products After J&J Recall Over Cancerous Chemical - 7/15/2021
Pfizer Recalls Anti-Smoking Drug Chantix Due To Cancer-Causing Chemical - 7/21/2021
Pfizer Recalls All Lots Of Anti-Smoking Drug Over Carcinogen Presence - 9/16/2021
Pfizer Recalls Some Blood Pressure Drugs Nationwide Over Potential Cancer Risk - 3/22/2022